| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.20B | 33.77B | 28.57B | 26.84B | 27.30B | 27.69B |
| Gross Profit | 4.77B | 4.31B | 3.77B | 3.37B | 4.27B | 4.75B |
| EBITDA | 4.46B | 4.01B | 1.40B | 918.00M | 1.73B | 2.39B |
| Net Income | 2.50B | 2.19B | 415.00M | 123.00M | 775.00M | 1.33B |
Balance Sheet | ||||||
| Total Assets | 35.71B | 37.76B | 33.67B | 28.79B | 27.79B | 25.05B |
| Cash, Cash Equivalents and Short-Term Investments | 2.54B | 3.08B | 2.20B | 2.32B | 3.25B | 1.48B |
| Total Debt | 8.89B | 10.78B | 9.02B | 6.45B | 4.95B | 4.69B |
| Total Liabilities | 23.43B | 25.44B | 23.26B | 18.86B | 17.96B | 15.73B |
| Stockholders Equity | 12.27B | 12.31B | 10.41B | 9.93B | 9.83B | 9.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.03B | -2.51B | -2.21B | 2.32B | -1.01B |
| Operating Cash Flow | 0.00 | -2.33B | -1.09B | -1.16B | 3.15B | -137.00M |
| Investing Cash Flow | 0.00 | 1.70B | -1.46B | -1.10B | -1.08B | -878.00M |
| Financing Cash Flow | 0.00 | 1.51B | 2.42B | 1.33B | -287.00M | 912.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥15.50B | 5.62 | ― | 1.56% | 22.31% | 101.45% | |
77 Outperform | ¥17.15B | 8.31 | ― | 1.01% | 17.09% | 43.01% | |
72 Outperform | ¥4.15B | 8.42 | ― | 2.59% | -21.00% | -7.27% | |
71 Outperform | ¥10.07B | 9.79 | ― | 4.72% | 3.49% | 9.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥9.10B | 3.62 | ― | 2.53% | 12.27% | 682.78% | |
47 Neutral | ¥9.35B | 161.81 | ― | ― | 6.02% | -49.16% |